hotspot
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: In Gaza, a nonprofit 3D prints tourniquets and stethoscopes
Next article: In Gaza, a nonprofit 3D prints tourniquets and stethoscopes
explore
explore
-
Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs
2025-09-27 08:43 -
IRA could hurt research into orphan drugs for rare diseases
2025-09-27 08:18 -
Humans aren't the only ones with an imagination. Rats have it too
2025-09-27 08:16 -
Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs
2025-09-27 08:16 -
After Sarepta trial failure, Duchenne families brace for more debate
2025-09-27 07:17 -
Readout LOUD podcast: The Sarepta saga, decoding biotech hype
2025-09-27 07:03